Steven Horwitz, MD

Articles by Steven Horwitz, MD

Current Treatment of Peripheral T-cell Lymphoma

ByRobert Stuver, MD,Zachary D. Epstein-Peterson, MD,William T. Johnson, DO,Niloufer Khan, MD, MS,Natasha Lewis, MD,Alison J. Moskowitz, MD,Craig S. Sauter, MD,Steven Horwitz, MD

May 13th 2022

This review article written by Robert Stuver, MD, et al, reviews current and available treatments for peripheral T-cell lymphoma.

Therapy for Peripheral T-Cell Lymphomas: Where We Are and Where We Hope to Be

ByNeha Mehta-Shah, MD,Steven Horwitz, MD

August 15th 2015

Our standard therapies for peripheral T-cell lymphoma may cure a subset of patients, and thus far novel agents have not changed the outcomes for the majority.

Latest Updated Articles

Current Treatment of Peripheral T-cell Lymphoma
May 13th 2022
Therapy for Peripheral T-Cell Lymphomas: Where We Are and Where We Hope to Be
August 15th 2015

Steven Horwitz, MD

Articles by Steven Horwitz, MD

Current Treatment of Peripheral T-cell Lymphoma

Therapy for Peripheral T-Cell Lymphomas: Where We Are and Where We Hope to Be

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC